1 August 2026
When a promising healthtech company struggles to grow after a successful pilot, the diagnosis is often predictable. The sales process must improve. The website needs sharper messaging. The proposition should be simplified. More visibility is needed.
Sometimes that is true. But in healthcare, stalled growth is often not a marketing problem. It is an adoption problem. The technology may work while the surrounding system is not yet ready to use, fund, own or defend the change.
The problem is often not visibility
A company can be well known and still fail to scale. Healthcare organisations do not adopt technology because the product is visible. They adopt when the change fits clinical workflows, responsibilities, budgets and existing priorities.
If those questions are unresolved, more publicity can amplify the gap between the promise and the reality.
Healthcare does not adopt products. It adopts changes in practice
A digital tool may look simple from the outside, but adoption can change who does what, when information is reviewed, which professional remains accountable and how a patient moves through care.
That means the real proposition is not only the product. It is the new way of working around the product.
The user, buyer and risk owner are different people
In many markets the person who sees the value can also decide to buy. Healthcare is different. A clinician may use the technology, an executive may own the budget, procurement may run the process, IT may control integration and a medical director may carry part of the risk.
A credible growth story therefore has to work for several stakeholders at once without becoming vague.
A successful pilot proves less than many founders think
A pilot can demonstrate technical feasibility or early value. It does not automatically prove that the solution can scale across teams, locations or patient groups.
Decision makers want to know what the pilot required, how much support was needed, which workflows changed and whether the results remain credible outside the original setting.
Evidence must answer operational questions
Clinical or user evidence matters, but adoption also depends on practical evidence. Does the innovation save time? Does it create new tasks? Who monitors exceptions? What happens when the technology fails? Can it be integrated without adding complexity?
These questions are not secondary to the communication strategy. They shape the story that professionals and executives are willing to believe.
Positioning should start with the healthcare problem
Many healthtech companies position themselves around what the technology can do. Stronger positioning starts with the healthcare problem that must be solved and the conditions under which change becomes realistic.
The technology then becomes evidence of a position, rather than the position itself.
Adoption needs internal ownership
An innovation scales more easily when someone inside the healthcare organisation owns the change. That person needs a case they can explain to colleagues, management and other stakeholders.
PR can support that case by making the problem, evidence and relevance visible. It cannot replace internal ownership.
What to ask before scaling
Which healthcare problem becomes meaningfully different because of the innovation? Who must change behaviour for adoption to work? What evidence is strong enough for each stakeholder? What new responsibility does the solution create? And who inside the healthcare organisation can credibly own the change?
If those questions remain unanswered, the company may not have a communications problem yet. It may still be solving the wrong adoption problem.